BioTuesdays

Tag - Adamas Pharmaceuticals

Adamas Pharmaceuticals Logo

Adamas Pharma names Neil McFarlane as CEO

Adamas Pharmaceuticals (NASDAQ:ADMS) has appointed Neil McFarlane as CEO and a member of its board, effective Sept. 16. Gregory Went, Adamas’ founder, chairman and CEO, will transition to a strategic advisory role...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.